Insulin manufacturer registration fee provisions modified.

This bill modifies Minnesota's requirement for insulin manufacturers to pay an annual $100,000 registration fee. It directly affects insulin manufacturers selling in Minnesota by changing the exemption criteria for this fee. Manufacturers can now qualify for exemption if their sales revenue from insulin in Minnesota was less than 5% of all insulin sales in the state during the previous year. The change simplifies the process for smaller manufacturers to avoid the fee based on their market share.